Cellular Senescence: Review and Reagent Selection Guide

Cellular senescence research guide

Detect senescent cells.
Explore what changes
inside them.

From senescence markers to ROS, mitochondrial function, lysosomal activity and metabolic remodeling—find the methods and assays that fit your research question.

SPiDER-βGal, γ-H2AX and DAPI co-staining in fixed cells
SPiDER-βGal (green), γ-H2AX (red) and DAPI (blue) in fixed cells.
Data from the SPiDER-βGal product page ↗

What Do You Want to Learn about Senescent Cells?

01 / Start with your research question

Cellular senescence can be studied from several angles. Begin with the question you need to answer, then select complementary markers and functional assays.

Q1Are my cells senescent?

Start with SA-β-gal activity, then assess stable cell-cycle arrest and additional features suited to your model.

See 03 - How to detect and confirm senescent cells ↓
Q2How are cellular functions changing?

Explore ROS, mitochondria, lysosomes / autophagy, and metabolic remodeling.

See 04 - Functional changes associated with cellular senescence ↓
Q3Which assays should I combine?

See established application data and practical workflows for multi-parameter analysis.

See 05 - Practical senescence research workflows ↓

What Is Senescence?

02 / Understand the biology

Cellular senescence is a stress-responsive cellular state frequently associated with stable cell-cycle arrest, altered lysosomal activity, changes in metabolism and context-dependent secretory programs. Its roles can be beneficial or detrimental depending on the biological setting.

Identify

Senescence-associated markers

Assess markers linked to growth arrest, SA-β-gal activity, DNA damage, morphology, and secretory phenotype. Use orthogonal evidence rather than relying on one readout.

Characterize

Senescence-associated functional changes

Understand what happens after or alongside senescence induction, including changes in oxidative stress / redox balance, mitochondrial function, lysosomes / autophagy, and metabolism. These measurements explain phenotype and mechanisms, but do not establish senescence on their own.

See 04 - Functional changes associated with cellular senescence ↓
Important for interpretation: No single marker is universally specific for cellular senescence. Marker selection and biological interpretation must account for cell type, induction method, and experimental context. In tissue studies, expert guidelines recommend evidence from multiple senescence characteristics (Suryadevara et al., 2024; Ogrodnik et al., 2024).

How to Detect and Confirm Senescent Cells

03 / First, identify the phenotype

Senescent cells are identified by combining several independent features. SA-β-gal activity is the most widely used readout and a practical place to start, but confirm it with evidence of stable cell-cycle arrest and other features suited to your model.

Find an SA-β-gal method for your experiment

Select your sample, its state and your instrument to see the recommended product.

Sample
Sample state
Instrument
Tissue samples are analyzed by microscopy.

Recommended for this combination

SG03 (SG04 in the U.S.)Cellular Senescence Detection Kit - SPiDER-βGal

Single-cell green fluorescence imaging of SA-β-gal in living cells.

Bafilomycin A1 is included for the live-cell protocol.

Product details ↗
SG03 (SG04 in the U.S.)Cellular Senescence Detection Kit - SPiDER-βGal

Quantify the percentage of SA-β-gal-positive cells by flow cytometry.

Bafilomycin A1 is included for the live-cell protocol.

Product details ↗
SG05Cellular Senescence Plate Assay Kit - SPiDER-βGal

Measure SA-β-gal activity in many samples with a plate reader.

Cells are lysed for the readout, so the result is a well average, not individual cells.

Product details ↗
SG07Cellular Senescence Detection Kit - SPiDER Blue

Blue fluorescence leaves the green and red channels free for co-staining, including immunostaining.

Product details ↗
SG03 (SG04 in the U.S.)Cellular Senescence Detection Kit - SPiDER-βGal

Green fluorescence detection that also works with fixed cells.

For fixed cells, prepare pH 6.0 McIlvaine buffer separately.

Product details ↗
SG07Cellular Senescence Detection Kit - SPiDER Blue

Blue fluorescence for multicolor flow cytometry (Pacific Blue channel).

Product details ↗
SG03 (SG04 in the U.S.)Cellular Senescence Detection Kit - SPiDER-βGal

Green fluorescence detection that also works with fixed cells.

For fixed cells, prepare pH 6.0 McIlvaine buffer separately.

Product details ↗
SG07Cellular Senescence Detection Kit - SPiDER Blue

Plate reader detection of SA-β-gal in fixed cells.

Product details ↗
SG02SPiDER-βGal

Fluorescent probe for SA-β-gal imaging in tissue, such as frozen sections.

Reagent only, not a kit. Fixation can lower β-gal activity, so optimize the fixation conditions.

Product details ↗

Which markers complement SA-β-gal?

SA-β-gal is a practical first readout, but it is not specific on its own. Confluent or starved cells can also stain positive. Combine it with independent features of senescence such as the markers below.

Readout What is measured Method / instrument What it tells you
p16 / p21 Protein or mRNA levels of CDK inhibitors p16INK4a and p21CIP1 Immunostaining (microscope)
Western blot
qPCR
Expression of CDK inhibitors associated with cell-cycle arrest.Increased expression supports senescence assessment but does not establish senescence on its own.
Ki-67 / EdU Ki-67 protein expression
or EdU incorporation during DNA synthesis
Ki-67 immunostaining or EdU labeling
(microscope, flow cytometer)
Reduced proliferative activity or DNA synthesis during the observation period.Negative results alone do not establish stable arrest or distinguish senescence from quiescence or differentiation.
γH2AX Phosphorylated histone H2AX
(nuclear foci or overall protein levels)
Immunofluorescence for foci (microscope)
Western blot for protein levels
Evidence consistent with DNA-damage signaling, including responses to double-strand breaks and replication stress.γH2AX is not specific to senescence.
SASP-related factors Secreted proteins such as IL-6, IL-8 and MMPs
or mRNA levels of corresponding genes
ELISA or multiplex assays for secreted proteins
(culture supernatant)
qPCR for mRNA (cells)
Changes in SASP-related factors.Profiles vary with cell type, inducer and time, and these factors are also produced by non-senescent cells. mRNA levels do not directly measure secretion.

Functional Changes Associated with Cellular Senescence

04 / Characterize the senescent state

After confirming the senescent phenotype, ask what is changing inside the cell. The four research themes below connect major senescence-related questions to measurable parameters and existing Dojindo methods.

Oxidative stress & redox balance

Does ROS production change during senescence?

Explore the relationship between cellular ROS, mitochondrial superoxide, DNA damage and antioxidant capacity.

MeasureTotal ROS · mtROS · GSH/GSSG

Mitochondrial dysfunction

Is mitochondrial function altered in senescent cells?

Investigate mitochondrial membrane potential, oxygen consumption, and mitochondrial quality control.

MeasureMembrane potential (ΔΨm) · Mitophagy · Oxygen consumption

Lysosome & autophagy

Does increased lysosomal activity mean normal lysosomal function?

Separate lysosomal staining, acidification and autophagic flux. An increase in SA-β-gal or lysosomal mass does not by itself demonstrate normal degradative capacity.

MeasureLysosomal pH · Organelle features · Autophagic flux

Explore Detection Methods

Metabolic remodeling

Are glycolysis and redox metabolism changing?

Examine NAD+/NADH balance and energy-pathway changes. Glycolysis and oxidative phosphorylation responses can differ among senescence models.

MeasureNAD+/NADH · Glycolysis/OXPHOS · Lactate

Explore Detections Methods

Science Notes are Dojindo's summaries of recent research. More topics are available in the Science Note back numbers ↗

Practical Workflows and Supporting Data

05 / Application data & workflows

Practical Workflows and Supporting Data

Select a workflow to view application data directly, examine the results and experimental conditions, and navigate to relevant reagents. Each tab makes clear whether the figures come from one model or separate reference experiments.

A549 · DOX inductionSame cells · FCM

SA-β-gal and oxidative stress

Representative application results from doxorubicin-induced senescent A549 cells. Fluorescence signals are shown directly rather than behind a separate link.

APPLICATION DATA · CTRL VS DOX · FLOW CYTOMETRY

SPiDER Blue flow cytometry histograms: non-stained, control, and DOX-treated A549 cells
SA-β-gal · SPiDER Blue
Total ROS flow cytometry histograms: control and doxorubicin-treated cells
Total ROS · R253
Gamma H2AX flow cytometry histograms of control and doxorubicin-treated cells
DNA damage · γH2AX

Figures: Dojindo SG07 product page, Technical info. Click the product page for the full-resolution originals.

What the data showIn DOX-induced A549 cells, senescence-associated SA-β-gal, total ROS and γH2AX staining signals are elevated relative to control cells. These represent complementary phenotypes, not three independent proofs of senescence.

Experimental outline

  • Model: A549 cells; DOX 0.2 μM for 3 days, then normal medium for 3 days.
  • Measurement: flow cytometry, Pacific Blue / FITC / Cy3 channels.
  • Staining order: ROS probe → fixation → SPiDER Blue → γH2AX staining.

Reagents used · Product pages

γH2AX-Red was also used. Confirm current kit availability and product code prior to publication.

Expand full experimental conditions and staining sequence
  1. DOX-induce A549 cells (0.2 μM for 3 days, followed by 3 days in normal medium).
  2. Prepare cell suspension and stain live cells with Photo-oxidation Resistant DCFH-DA for 30 min at 37°C.
  3. Fix with 4% PFA/PBS (30 min at 4°C or overnight), then stain with SPiDER Blue working solution (15 μM, 30 min at 37°C).
  4. Permeabilize, block and stain with anti-γH2AX antibody plus an appropriate red secondary antibody.
  5. Analyze on a flow cytometer with suitable controls and compensation.

Condensed for preview. Use the complete SG07 technical protocol and manual for volumes, centrifugation conditions and wash steps.

Source: SG07 — Multiple staining of oxidative stress-related markers in DOX-induced senescent cells ↗

DOX-induced senescence modelSeparate wells / assays

SA-β-gal and metabolic changes

Metabolic remodeling evaluated with senescence-associated markers, mitochondrial membrane potential, NAD/NADH, ATP and lactate. The original summary figure is shown here; publication-ready panels should use individual original graphs if available.

APPLICATION DATA · MULTIPARAMETER METABOLIC SHIFT

Original full-width Dojindo figure: doxorubicin-treated senescence model, DNA damage, SA-beta-gal staining, mitochondrial membrane potential, and metabolic measurements.Open original figure at full size ↗

Dojindo G270 technical information: “Experiment Example: Cellular Senescence with Metabolic shift”. The original is a combined overview image, not an independently quantified chart for every assay.

What the data showOne DOX-induced senescence model can be characterized with complementary SA-β-gal, mitochondrial function and biochemical readouts. Interpret direction and size of changes from the original individual graphs, not by assuming a universal metabolic shift.

Experimental outline

  • Establish senescent and non-senescent control cultures.
  • Use matched replicate wells for SA-β-gal, ΔΨm, NAD+/NADH, ATP and lactate measurements.
  • Separate assays avoid incompatible treatments and spectral overlap.
Expand recommended sample allocation and assay notes
  1. Prepare matched senescent and control cultures from the same experimental model.
  2. Allocate independent replicate wells for microscopy, cell-based fluorimetry, lysate-based NAD/NADH, and ATP/lactate assays.
  3. Analyze each endpoint using its validated product manual, normalization controls and treatment schedule.
  4. Compare the endpoints at the biological level only after documenting assay-specific conditions.

Exact protocol and experimental details must be drawn from the original G270 application and the related manuals; a combined one-tube protocol is not implied.

Source: G270 product page — “Cellular Senescence with Metabolic shift” ↗

Separate experiments

SA-β-gal and lysosomal changes

Two existing datasets illustrate relevant assays individually. They come from different cell models and experiments; no combined senescence–lysosome result is claimed.

Evidence distinction: left: WI-38 senescence-specific SA-β-gal result; right: HeLa lysosomal acidification perturbation result. These figures must not be presented as a joint result from a single senescence sample.

AVAILABLE REFERENCE DATA · TWO SEPARATE ASSAYS

Doxorubicin-treated WI-38 cells: higher SA-beta-gal signal in microplate assay
A · SA-β-gal activity in DOX-treated WI-38 cells (SG05)
HeLa cells treated with bafilomycin A1: pHLys Red and LysoPrime Deep Red confocal fluorescence images
B · Lysosomal acidification in HeLa cells with Bafilomycin A1 (L265)

Source images: SG05 and L265 manuals. Different models, different perturbations, separate evidence.

Research rationaleMeasure senescence-associated SA-β-gal and characterize lysosomal abundance and acidification as separate endpoints in a validated senescence model. A change in lysosome staining alone is not evidence of altered degradation.

Proposed strategy

  • Use matched, separately processed wells from the same senescence model.
  • SG05: senescence-associated SA-β-gal plate readout; normalize for cell number.
  • L264 + L265: separate lysosomal mass-associated staining from acidification-associated fluorescence.
Expand proposed workflow and original reference conditions
  1. Induce senescence in the selected cell model; prepare well-matched untreated controls.
  2. Perform the SG05 assay in separate wells (lysis, reaction and cell number normalization according to the manual).
  3. For lysosome characterization in other matched wells, apply LysoPrime Deep Red and pHLys Red according to their manuals with appropriate inhibitor controls.
  4. Validate dye compatibility, treatments and the biological interpretation before treating results as a combined workflow.

Original datasets: WI-38 DOX induction and SA-β-gal data are described in the SG05 manual. The pHLys experiment used HeLa cells and Bafilomycin A1, described in the L265 manual.

Sources: SG05 manual ↗ · L265 manual ↗

Product Classification

Product Classification